Our Firm is monitoring this litigation closely, as we have received inquiries from several individuals who claim to have experienced similar complications while using Xarelto.
New York, New York (PRWEB) October 03, 2014
Xarelto lawsuits (http://www.xareltolawsuitcenter.com) alleging the blood thinner caused some patients to suffer uncontrollable internal bleeding and other life-threatening complications continue to mount in U.S courts, Bernstein Liebhard LLP reports. According to a new complaint filed on September 26th in the U.S. District Court, Southern District of Illinois, a woman from that state claims that Xarelto caused her husband to suffer internal bleeding and a bilateral pulmonary embolism that resulted in his death. Among other things, the lawsuit asserts that the complications experienced by the Plaintiff’s husband could have been avoided had the manufacturers of Xarelto not withheld critical safety information from consumers and the medical community. (Case 3:14-cv-01042-DRH-PMF)
“Our Firm is monitoring this litigation closely, as we have received inquiries from several individuals who claim to have experienced similar complications while using Xarelto,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently offering Xarelto case reviews to people who allegedly suffered serious injuries from the blood thinner, including uncontrollable bleeding, strokes, deep vein thrombosis or pulmonary embolism.
Xarelto, which is jointly marketed by Bayer and Johnson & Johnson, belongs to a new class of anticoagulants known as direct thrombin inhibitors. Like any blood thinner, the medication can sometimes cause patients to experience internal hemorrhaging. However, no antidote has yet been approved to reverse Xarelto bleeding. *
In recent months, a growing body of research has called the safety of Xarelto into question. For example, a report published in May by the Institute of Safe Medicine Practices revealed that the U.S. Food & Drug Administration had received a total of 680 Xarelto adverse event reports in the first quarter of 2013. For the first time, reports of complications associated with the medication outpaced those associated with Pradaxa, another blood thinner in the same class, according to the ISMP.**
In August, a study published in the Journal of Neurosurgery found that internal bleeding associated with Xarelto is more difficult to stop when compared to some other blood thinners.***
Individuals who were allegedly harmed by Xarelto may be entitled to compensation for medical bills, lost wages, pain and suffering, and more. To learn more about filing a Xarelto lawsuit, please visit Bernstein Liebhard LLPs website, or call 800-511-5092 to schedule a free, no obligation case review.
*fda.gov/downloads/Drugs/DrugSafety/UCM280333.pdf, FDA, March 2014
**ismp.org/quarterwatch/pdfs/2013Q1.pdf, Institute for Safe Medication Practices, May 7, 2014.
***thejns.org/doi/pdf/10.3171/2014.8.paradigm, The Journal of Neurosurgery, August 1, 2014
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP